Dewcef-S 500mg/250mg Injection
Marketer
Haledew Remedies
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Dewcef-S 500mg/250mg Injection
Cefixime and Sulbactam injection (500mg/250mg), a dual-action antibiotic, combats various bacterial infections by hindering microbial proliferation. Administration must be solely under a physician's guidance; strict adherence to the prescribed dosage and schedule is crucial for effective treatment. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate emergency care for allergic reactions like rash, itching, swelling, or respiratory distress. Prior to commencing treatment, disclose all current medications and pre-existing conditions, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and proper hydration contribute to faster recovery. Your doctor might order lab tests to monitor the medication's effects.
Uses of Dewcef-S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Dewcef-S 500mg/250mg Injection:
Administering this medication is the responsibility of your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Dewcef-S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Dewcef-S 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Dewcef-S 500mg/250mg Injection works:
The injectable formulation Dewcef-S (500mg/250mg Ceftriaxone/Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse interactions between Dewcef-S 500mg/250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Cefixime and sulbactam injection (500mg/250mg), marketed as Dewcef-S, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful consequences for the fetus; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Dewcef-S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Dewcef-S 500mg/250mg Injection might cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Dewcef-S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication Dewcef-S (500mg/250mg) requires careful administration to individuals with significant hepatic impairment. Dosage modification of Dewcef-S (500mg/250mg) injection may be necessary; physician consultation is advised. Dosage alteration for Dewcef-S (500mg/250mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Dewcef-S 500mg/250mg Injection :
Should you inadvertently skip a Dewcef-S 500mg/250mg Injection, seek medical advice.
Facts to Know About Dewcef-S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently